https://www.selleckchem.com/pr....oducts/tegatrabetan.
Distal left main (LM) bifurcation disease is one of the most challenging lesion subsets for percutaneous coronary intervention (PCI) and optimal stenting strategy for such complex lesions is still debated. This study aimed to compare clinical outcomes following single versus dual stenting for true distal LM bifurcation lesions. Patients with true distal LM bifurcation lesions (type 1,1,1 or 0,1,1 both left anterior descending and circumflex artery 2.5 mm diameter) receiving PCI with drug-eluting stents (DES) from two large clin
Like
Comment
Share
